Emprimus, LLC
USPTO PatentsView assignee record - 10 granted patents across 8 technology areas, recorded in grant years 2015–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: H02H (Emergency Protective Circuit Arrangements).
The verdict
According to USPTO PatentsView, Emprimus ranks #26,224 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 8 technology areas.
- #26,224
- of 49,997 US assignees by volume
- 49th percentile
- by Innovation Score (34.9/100)
- 16.5
- avg claims per patent
- -89%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R26224 · US Corporation #26,224 · 10 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 10 grants
- MID-PACK #26,224/49,997
- PHOTO-FINISH Ellodi Pharmaceuticals
- CPC-NARROW H02H · 8 areas
- INNOV-THIN 34.9/100
- CLAIMS-RICH 16.5 claims/avg
- TYPE-USCORP US Corporation
- VEL-DROP -89% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Ellodi Pharmaceuticals, L.P. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Emprimus’s 34.9 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Emprimus
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Emprimus · this assignee
Emprimus · this assignee
35 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Emprimus's Innovation Score is 34.9/100 (49th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Emprimus?
Each dot is one of Emprimus’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Emprimus’s own 16.5 claims/patent is at or below the 18.2 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Emprimus's grants concentrate
Emprimus, LLC is a focused PatentsView assignee: 8 CPC subclasses with 50% of grants classified under H02H (Emergency Protective Circuit Arrangements). Peak complete grant year is 2015 (3 grants) versus a trough of 1 in 2016. By volume, Emprimus sits between Ellodi Pharmaceuticals, L.P. and Enforcement Video, LLC.
Emprimus's three-year grant acceleration
Emprimus, LLC shows 1 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Emprimus's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Ellodi Pharmaceut…
Ellodi Pharmaceuticals, L.P.
10 patents
- Elmdene Group
Elmdene Group, Ltd.
10 patents
- Elmo
Elmo Co., Ltd.
10 patents
- Emerald Energy NW
Emerald Energy NW, LLC
10 patents
- Enchroma
EnChroma, Inc.
10 patents
- Endophys Holdings
Endophys Holdings, LLC
10 patents
- Energy Integration
Energy Integration, Inc.
10 patents
- Enforcement Video
Enforcement Video, LLC
10 patents
- Emprimus ◀
Emprimus, LLC
10 patents
What this shows Emprimus holds 10 patents at rank #26,249, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Emprimus
By rank, the assignees closest to #26,249 in granted patent volume.
- Ellodi Pharmaceuticals, L.P. #26,245 · 10 patents
- Elmdene Group, Ltd. #26,246 · 10 patents
- Elmo Co., Ltd. #26,247 · 10 patents
- Emerald Energy NW, LLC #26,248 · 10 patents
- EnChroma, Inc. #26,250 · 10 patents
- Endophys Holdings, LLC #26,251 · 10 patents
- Energy Integration, Inc. #26,252 · 10 patents
- Enforcement Video, LLC #26,253 · 10 patents
Leaders in H02H (Emergency Protective Circuit Arrangements)
Other assignees with the most granted patents in Emprimus's primary technology class.
Emprimus's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
35 49th percentile higher than 49% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 3 | 30.0% |
| 2016 | 1 | 10.0% |
| 2017 | 3 | 30.0% |
| 2018 | 1 | 10.0% |
| 2019 | 1 | 10.0% |
| 2022 | 1 | 10.0% |
Which technologies does Emprimus, LLC patent most?
Top 8 of 8 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Emprimus, LLC's patent record in context - here's where to go next.
- Emprimus, LLC's lead technology class is H02H (Emergency Protective Circuit Arrangements), 50% of its portfolio - see every assignee active in that class. Explore H02H
- Ranked #26,224 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Emprimus, LLC against Ellodi Pharmaceuticals, L.P., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 34.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.